Delivery Order SPE2DB20D3101-SPE2DB22FH6W9
Award Date 2/2/22
Potential Completion Date 2/3/22
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The $20,358.39 firm fixed-price contract has a completion date of March 13, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D3104|SPE2DB23FV4N1) valued at $2,666.97 for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The award was made on January 4, 2023, with a completion date of January 5, 2023, and is a firm fixed-price contract. The contracting agency is the Defense Logistics Agency (DLA), a defense agency, and the contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,577.16 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,744.44 for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,367.78 for the supply of XIFAXAN 550 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $6,879.15 for the supply of the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through June 26, 2023. The contract is a Firm Fixed Price arrangement and was not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,762.05 firm-fixed-price delivery order is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen Drug Corp holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $63,877.36. The contract was awarded by the Defense Logistics Agency (DLA) and is for the delivery of the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The award has an ultimate completion date of May 22, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,094.58 Firm Fixed Price Delivery Order is for the supply of XIFAXAN 550 MG Tablets. The award has an ultimate completion date of September 11, 2023 and does not include a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,082.84 firm fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets, a specialty pharmaceutical product. The contract has a completion date of February 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. Cencora, Inc. holds a significant $999,999,999.00...